AI assistant
Sending…
EXACT SCIENCES CORP — Director's Dealing 2018
Mar 1, 2018
30597_dirs_2018-02-28_52d88b1d-6efe-4006-8dbb-eddc3cd7a2eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-02-27
Reporting Person: Elliott Jeffrey Thomas (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-27 | Stock Option (right to buy) | $44.37 | A | 16700 | Acquired | 2028-02-28 | Common Stock (16700) | Direct |
| 2018-02-27 | Restricted Stock Units | $ | A | 20100 | Acquired | Common Stock (20100) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21012 | Direct |
| Common Stock | 781 | Indirect |
Footnotes
F1: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
F3: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
More from EXACT SCIENCES CORP
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23